Enzymotec Opens Shanghai Office
The branch aims to support growing business activities in China.
Lipid ingredients specialist Enzymotec (Migdal HaEmeq, Israel) has opened an office in Shanghai-a branch the company says aims to support growing business activities in China. The company has a presence in more than 40 countries.
“Southeast Asia in general, and China in particular, have become key markets for us due to the economic developments in the region,” said Enzymotec CEO Ariel Katz, PhD, in a press statement.
Enzymotec develops and manufactures lipid-based nutraceutical ingredients. Its business is divided in three segments: infant nutrition (with InFat, a clinically proven ingredient that mimics the fat of human milk and is marketed through Advanced Lipids AB, a joint venture of AAK and Enzymotec); bioactives; and pharmaceutical.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
